Literature DB >> 19075030

Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Dayanjan S Wijesinghe1, Preeti Subramanian, Nadia F Lamour, Luciana B Gentile, Maria H Granado, Alicja Bielawska, Zdzislaw Szulc, Antonio Gomez-Munoz, Charles E Chalfant.   

Abstract

Previously, our laboratory demonstrated that ceramide-1-phosphate (C1P) specifically activated group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) in vitro. In this study, we investigated the chain length specificity of this interaction. C1P with an acyl-chain of >or=6 carbons efficiently activated cPLA(2)alpha in vitro, whereas C(2)-C1P, was unable to do so. Delivery of C1P to cells via the newly characterized ethanol/dodecane system demonstrated a lipid-specific activation of cPLA(2)alpha, AA release, and PGE(2) synthesis (EC(50) = 400 nM) when compared to structurally similar lipids. C1P delivered as vesicles in water also induced a lipid-specific increase in AA release. Mass spectrometric analysis demonstrated that C1P delivered via ethanol/dodecane induced a 3-fold increase in endogenous C1P with little metabolism to ceramide. C1P was also more efficiently delivered (>3-fold) to internal membranes by ethanol/dodecane as compared to vesiculated C1P. Using this now established delivery method for lipids, C(2)-C1P was shown to be ineffective in the induction of AA release as compared with C(6)-C1P, C(16)-C1P, and C(18:1) C1P. Here, we demonstrate that C1P requires >or=6 carbon acyl-chain to activate cPLA(2)alpha. Thus, published reports on the biological activity of C(2)-C1P are not via eicosanoid synthesis. Furthermore, this study demonstrates that the alcohol/dodecane system can be used to efficiently deliver exogenous phospholipids to cells for the examination of specific biological effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075030      PMCID: PMC2739767          DOI: 10.1194/jlr.M800367-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  Enhanced ceramide-induced apoptosis in ceramide kinase overexpressing cells.

Authors:  Christine Graf; Philipp Rovina; Loïc Tauzin; Andrea Schanzer; Frédéric Bornancin
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

2.  Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells.

Authors:  Poulami Mitra; Michael Maceyka; Shawn G Payne; Nadia Lamour; Sheldon Milstien; Charles E Chalfant; Sarah Spiegel
Journal:  FEBS Lett       Date:  2007-01-25       Impact factor: 4.124

3.  Endothelin-1 enhances eicosanoids-induced coronary smooth muscle contraction by activating specific protein kinase C isoforms.

Authors:  Z N Sirous; J B Fleming; R A Khalil
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  Multiple eicosanoid-activated nonselective cation channels regulate B-lymphocyte adhesion to integrin ligands.

Authors:  Xiaohong Liu; Peimin Zhu; Bruce D Freedman
Journal:  Am J Physiol Cell Physiol       Date:  2005-10-26       Impact factor: 4.249

5.  Substrate specificity of human ceramide kinase.

Authors:  Dayanjan S Wijesinghe; Autumn Massiello; Preeti Subramanian; Zdzislaw Szulc; Alicja Bielawska; Charles E Chalfant
Journal:  J Lipid Res       Date:  2005-09-18       Impact factor: 5.922

6.  On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase.

Authors:  Helena Van Overloop; Yves Denizot; Myriam Baes; Paul P Van Veldhoven
Journal:  Biol Chem       Date:  2007-03       Impact factor: 3.915

7.  Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain.

Authors:  Robert V Stahelin; Preeti Subramanian; Mohsin Vora; Wonhwa Cho; Charles E Chalfant
Journal:  J Biol Chem       Date:  2007-04-30       Impact factor: 5.157

8.  Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis.

Authors:  Nadia F Lamour; Robert V Stahelin; Dayanjan S Wijesinghe; Michael Maceyka; Elaine Wang; Jeremy C Allegood; Alfred H Merrill; Wonhwa Cho; Charles E Chalfant
Journal:  J Lipid Res       Date:  2007-03-27       Impact factor: 5.922

Review 9.  Lipoxygenase metabolism: roles in tumor progression and survival.

Authors:  Graham P Pidgeon; Joanne Lysaght; Sriram Krishnamoorthy; John V Reynolds; Ken O'Byrne; Daotai Nie; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

Review 10.  Regulation of cell proliferation and apoptosis by bioactive lipid mediators.

Authors:  Joan Clària
Journal:  Recent Pat Anticancer Drug Discov       Date:  2006-11       Impact factor: 4.169

View more
  24 in total

1.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

2.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

3.  An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production.

Authors:  Young-Il Kim; Kyungho Park; Jong Youl Kim; Ho Seong Seo; Kyong-Oh Shin; Yong-Moon Lee; Walter M Holleran; Peter M Elias; Yoshikazu Uchida
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

4.  Analysis of Molecular Species Profiles of Ceramide-1-phosphate and Sphingomyelin Using MALDI-TOF Mass Spectrometry.

Authors:  Ryouhei Yamashita; Yumika Tabata; Erina Iga; Michiyasu Nakao; Shigeki Sano; Kentaro Kogure; Akira Tokumura; Tamotsu Tanaka
Journal:  Lipids       Date:  2015-12-22       Impact factor: 1.880

5.  Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).

Authors:  Hung Caohuy; Qingfeng Yang; Yvonne Eudy; Thien-An Ha; Andrew E Xu; Matthew Glover; Raymond A Frizzell; Catherine Jozwik; Harvey B Pollard
Journal:  J Biol Chem       Date:  2014-11-10       Impact factor: 5.157

6.  Ceramide 1-phosphate stimulates glucose uptake in macrophages.

Authors:  Alberto Ouro; Lide Arana; Patricia Gangoiti; Io-Guané Rivera; Marta Ordoñez; Miguel Trueba; Ravi S Lankalapalli; Robert Bittman; Antonio Gomez-Muñoz
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

7.  Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels.

Authors:  Dayanjan S Wijesinghe; Jeremy C Allegood; Luciana B Gentile; Todd E Fox; Mark Kester; Charles E Chalfant
Journal:  J Lipid Res       Date:  2009-08-04       Impact factor: 5.922

8.  Lipid Phase Separation and Protein-Ganglioside Clustering in Supported Bilayers Are Induced by Photorelease of Ceramide.

Authors:  Daniel M Carter Ramirez; Young Ah Kim; Robert Bittman; Linda J Johnston
Journal:  Soft Matter       Date:  2013-05-21       Impact factor: 3.679

Review 9.  The role of ceramide-1-phosphate in biological functions.

Authors:  L Alexis Hoeferlin; Dayanjan S Wijesinghe; Charles E Chalfant
Journal:  Handb Exp Pharmacol       Date:  2013

10.  Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase.

Authors:  Jennifer A Mietla; Dayanjan S Wijesinghe; L Alexis Hoeferlin; Michael D Shultz; Ramesh Natarajan; Alpha A Fowler; Charles E Chalfant
Journal:  J Lipid Res       Date:  2013-04-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.